Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Recent selling
View:
Post by fredgoodwinson on Jul 24, 2020 7:28am

Recent selling

Puzzled as to the weakness of the stock right now as irrespective of NMIBC there should be strong hope value in the pre-clinical progress of TLD-1433 in NSCLC at Roswell Park and Rutherrin for GBM in Toronto. 

 

Might this have to do with the IP ownership of Sherri`s super compounds as referred to in the ann below?

 

https://web.tmxmoney.com/article.php?newsid=5063081139073863&qm_symbol=TLT

 

 

We are left guessing but the volume of selling at this low price - below the level at which warrants retained from the last raise would give a profit - is unsettling and the current silence reminiscent of the long pause in the middle of Phase 1B which we were only later told co-incided with a need to re-calibrate the treatment.

 

Shareholders deserve an update - good or bad - and it is a pathetic excuse to hide behind Covid as a reason not to provide one.

 

Comment by Thor6570 on Jul 24, 2020 7:47am
Covid aside ! Mgt has lost the trust of many investors. Why buy at all ? These warrants on sale have kneecaped this stock. There financial moves have been nothing short of disastrous, Is the current CEO this bad ? Or is the Engineering department running the show ?
Comment by jojomarch on Jul 24, 2020 8:01am
The " ELECTRIC ENGINEERING " dept has been running the show from day one . That dept should of engineered a Ph1b in the USA in 2015 and we would not be sitting at 20 cents a share with extreme dilution IMO . Happy Friday
Comment by Quattro74 on Jul 24, 2020 10:10am
  Hmm, I don't see enuf volume on the warrant side to 'warrant' them as a cause. I think it could have been some sizeable stops just under .20c got run by the MMs yesterday so that some lucky investor could get their price. I mean someone got a great deal yesterday. Lots of shares traded.
Comment by Quattro74 on Jul 24, 2020 10:06am
Well, any questions regarding IP ownership is right in the article. Theralase has an agreement with Dr. McFarland on these supercompounds.
Comment by fredgoodwinson on Jul 24, 2020 10:25am
Hi Quattro - yes that is implied by what the TLT men suggest but didn`t mysef see a specific reference to TLT having any IP entitlement to the supercompounds and it`s possible that Sherri may have been working out of the States at the time.
Comment by Quattro74 on Jul 24, 2020 10:49am
Ok, yeah. I'd rather not have to 'read the tea leaves' myself. I'd love a nailed down PR on this too.
Comment by fredgoodwinson on Jul 24, 2020 10:54am
That`s the way it`s always been with these but that supercompound ann was something else - like the best thing that`s ever been discovered but then not a word on it here or anywhere else ever since.
Comment by Quattro74 on Jul 24, 2020 12:25pm
I've mentioned this before, just because these compounds are 10,000x better than 1433/Rutherrin does not mean they will be as practaca(b)l(e) in the clinical setting. 1433 seems to be particularly well suited to using in humans ATM. Who knows where they are in the lab with these Super Compounds? I'm betting they were looking at test tube info for that PR.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250